Richter raises guidance
Hungarian drugmaker Richter on Tuesday slightly raised its projection for revenue growth this year to 3%, calculated in Euro. Speaking after the company published its third-quarter earnings report, CEO Erik Bogsch said sales growth in Russia, Ukraine and Poland is now seen to be better than expected. Sales are now expected to fall no more than 15% in Hungary this year, as opposed to the earlier projected 15-20%, he added. Richter's Euro-term revenue rose 3.6% in Q1-Q3 from the same period a year earlier, the earnings report showed. Bogsch said a strategic agreement the company recently signed with the government offered stability and predictability for the drug subsidy system and the state's holding in the company.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.